An in vitro complementation reaction leading to the assembly of bacteriophage 480 tails from component proteins is described. Tail assembly occurs when a lysate of any mutant in cistron 13 is mixed with a second lysate of a mutant in any of the other cistrons involved in tail formation. Lysates of mutants that are blocked in tail formation contain phage heads that can unite with free tails to form infective particles. The rate of the complementation reaction shows little dependence upon temperature, suggesting that the assembly depends largely upon the kinetic encounter of the interacting components. The tail component missing in cistron 13 mutant lysates was purified approximately 55-fold and shown to be, at least in part, a protein having a molecular weight of approximately 22,000. This protein was also released from highly purified infective 480 particles after osmotic shock followed by heattreatment, suggesting that it most probably is an integral structural protein of the phage tail. Lysates of mutants of bacteriophage X that are defective in tail formation were shown to contain a tail component identical with or similar to the 4)80 cistron 13 product.
An in vitro complementation reaction leading to the assembly of bacteriophage 480 tails from component proteins is described. Tail assembly occurs when a lysate of any mutant in cistron 13 is mixed with a second lysate of a mutant in any of the other cistrons involved in tail formation. Lysates of mutants that are blocked in tail formation contain phage heads that can unite with free tails to form infective particles. The rate of the complementation reaction shows little dependence upon temperature, suggesting that the assembly depends largely upon the kinetic encounter of the interacting components. The tail component missing in cistron 13 mutant lysates was purified approximately 55-fold and shown to be, at least in part, a protein having a molecular weight of approximately 22,000. This protein was also released from highly purified infective 480 particles after osmotic shock followed by heattreatment, suggesting that it most probably is an integral structural protein of the phage tail. Lysates of mutants of bacteriophage X that are defective in tail formation were shown to contain a tail component identical with or similar to the 4)80 cistron 13 product.
The morphogenesis of the related bacteriophages )80 and X is controlled by two gene clusters located on the left arm of the chromosome of each phage (3, 4, 10) . The proximal gene cluster is involved in tail formation, whereas the distal one specifies head formation (4, 10, 13) . Furthermore, in vitro complementation experiments coupled with observations with the electron microscope (7, 8) have shown that phage mutants defective in head formation synthesize normal tails and that tail mutants produce normal heads.
Weigle (14) showed that the union of X heads and tails to form infective particles depends solely on the probability of encounter of the two components and that no other factor is necessary for the reaction.
In vitro cross-complementation studies be- assembly 480 tails. One of the components in this reaction, the cistron 13 product, has been identified as a relatively heat stable, low-molecular-weight protein. A similar protein was shown to exist in lysates of some of the mutants in bacteriophage X that are blocked in tail formation.
MATERIALS AND METHODS
Chemicals and media. Mitomycin C (crystalline) and bovine serum albumin (fraction V) were purchased from the Sigma Chemical Co. Egg white lysozyme, cs-chymotrypsinogen, ovalbumin, bovine pancreas deoxyribonuclease I (crystalline), ribonuclease (crystalline), trypsin (2X crystallized), and soybean trypsin inhibitor were products of Worthington Biochemical Corp.
Sephadex G-100 (particle size, 40 to 120 ,um) was purchased from Pharmacia Fine Chemicals Inc. In vitro complementation leading to tail assembly.
Tests for in vitro complementation between any two mutant lysates defective in tail formation were performed by incubating 0.3 ml of each at 37 C for 2 hr, after which the reaction was essentially complete. Since the above lysates already contain heads that can unite with tails to form infective units, tail assembly was therefore estimated by measuring the increase in the number of infective units per milliliter of incubation mixture.
Assay for cistron 13 product. The assay mixture for cistron 13 protein in the in vitro tail assembly reaction contained, in a total volume of 0.6 ml, 0.3 ml of sus 31 lysate (7.0 mg/ml of protein) and a dilution of cistron 13 protein that resulted in the assembly of between 2 X 105 and 3 X 106 plaque-forming units in a 2-hr incubation period. A unit of activity is equal to the formation of one infective unit of the bacteriophage. All lysates and protein fractions were in 0.02 M potassium phosphate buffer (pH 7.2). Sephadex-gel filtration. Sephadex G-100 (particle size, 40 to 120 j.m) was suspended in 0.02 M potassium phosphate buffer (pH 7.2) and allowed to swell for 2 to 3 days at 4 C. Fine particles were removed by decantation. Gel suspensions were deaerated under reduced pressure and packed into columns. The gel bed was equilibrated with 0.02 M potassium phosphate buffer (pH 7.2) by maintaining a flow of the buffer through the column for 2 days at a rate of approximately 20 ml/hr. All gel filtration experiments were performed at 4 C. Other details of the procedure are found in the legends to Fig. 5 and 6. The proteins used as standards for molecular weight determination were dissolved in the equilibration buffer at a concentration of 2.0 mg/ml. A volume of 2.0 ml of the protein solution was applied to the column. The proteins in the effluent were estimated by measuring the absorbance at 280 nm. Symmetrical peaks with sharp maxima were obtained in all cases. The molecular weights of the standard proteins used were: a-chymotrypsinogen, 25,000 (15), ovalbumin, 45,000 (12); bovine serum albumin (fraction V), 67,000 (9); lysozyme, 14,400 (11) . RESULTS In vitro complementation among mutants blocked in tail formation. In a previous publication (4) kinetics of complementation between lysates of 480 sus 31 (cistron 13) and sus 107 (cistron 10) leading to tail assembly and subsequent formation of phage-infective units are shown in Fig. 3 . The production of phage was measured by diluting and plating as a function of time. The background of active phage (leakers and revertants) in the lysates varies between 4 x 104 and 2 X 105 per ml. The production of infective phage is very rapid and is almost complete after 30 min. A decrease by a factor of about 2.5 in the rate was observed when the temperature of the reaction was lowered to 5 C, which is approximately equivalent to the increase in the viscosity of the reaction mixture. This suggests that the assembly is mainly dependent upon the probability of encounter of the interacting components.
Purification of the cistron 13 product. The product of cistron 13, which is found in lysates of mutants in other tail-specifying cistrons, was purified approximately 55-fold with a yield of 58(',. This was accomplished by a heattreatment step followed by filtration on Sephadex G-100 gel. The cistron 13 product was purified from sus 107 (cistron 10) lysates. The mixture is shown in Fig. 4 . A linear relationship was observed up to a rate of assembly of approximately 3 X 106i infective units in a 2-hr incubation period.
It was observed that cistron 13 product was relatively stable at high temperatures. This was taken advantage of in purifying this product. The first step in the purification involved incubating the sus 107 lysate (see above for preparation) at 92 C for 3 mmi. The precipitated proteins were removed by centrifugation at 2,000 X g for 10 mmn. This resulted in a purification of approximately 4.3n X with a yield of 87%. m the supernatant fluid from this step was then subjected to gel filtration on a Sephadex G-100 column. The pattern of fractionation on Sephadex G-100 is shown in Fig. 5 . Assay of fractions for ability to effect tail assembly when added to a lysate of sus 31 (cistron 13) showed that this activity is probably associated with a single component that eluted just after the bulk of proteins. The three fractions with highest activity were pooled and used for characterization studies. The specific activity of the pooled fractions was 3.1 X 107. Other details of gel filtration on Sephadex G-100 are given above and in the legend to Fig. 5 . A summary of the purification procedure is given in Table 2 .
Nature and properties of the cistron 13 product. Treatment of the partially purified preparation with trypsin (0.2 mg/ml at 37 C for 120 min) followed by addition of soybean trypsin inhibitor (0.4 mg/ml) resulted in 87(/c loss of activity in the complementation reaction. Incubation with either a mixture of trypsin (0.2 mg/ml) and trypsin inhibitor (0.4 mg /ml) or just trypsin inhibitor (0.4 mg/ml) had no effect. This suggests that the cistron 13 product is at least in part protein in nature. Furthermore, this product was insensitive to treatment with pancreatic deoxyribonuclease (50 ,g/ml) and ribonuclease (50 ,g/ml).
Estimation of the molecular weight of cistron 13 product was made by the gel filtration method with Sephadex G-100 (1). A plot of log1,, molecular weight versus elution volume is shown in Fig. 6 . The cistron 13 Release of the cistron 13 product from complete phage particles. The question asked here was whether the cistron 13 product is one of the tail structural components or does it merely direct the assembly of the tail proteins. One way of getting information pertaining to this is by examining purified complete phage particles for the presence of this product.
Highly purified wild-type 480 was prepared by ammonium sulfate fractionation, differential centrifugation, and banding twice in CsCl gradients according to a procedure described earlier (5) . A stock suspension of 480 (5 X 1012 plaque-forming units/ml) in 44% (w/w) CsCl solution was diluted 100-fold into 0.02 M potassium phosphate buffer (pH 7.0) and subsequently incubated at 92 C for 3 min. The phage preparation, which had lost its plaque-forming ability as a result of this treatment, was then assayed for content of the cistron 13 product by the in vitro complementation reaction. The result given at the bottom of Table 1 shows that this osmotically shocked and heat-inactivated 480 preparation does indeed contain the missing component in sus 31 lysates. This observation strongly suggests that the cistron 13 product is one of the protein tail components.
In vitro complementation between 480 cistron 13 mutants and X mutants defective in tail formation. These complementation tests were performed to determine whether the tail component missing in cistron 13 mutants can be supplied by mutants of bacteriophage X that are also defective in tail formation. The results presented in Table 3 show that lysates of X mutants 5 in cistrons L, H, K, M, and G contain the missing tail component in cistron 13 mutants. No complementation was observed with lysates of mutants in cistron I of X, which could mean that cistron 13 of 4t80,and cistron I of X specify the same component that is necessary for the tail assembly. DISCUSSION An in vitro complementation reaction leading to the assembly of 480 tails that subsequently interact with heads to form infective units was described. Complementation occurs when lysates of sus mutants in cistron 13, which are defective in tail formation but make complete heads, are mixed with lysates of mutants of other cistrons responsible for tail formation. This allowed the purification of the missing component in cistron 13 lysates. Since this missing component is made by all other cistrons involved in tail formation, it may at this time be assumed that it is the product of cistron 13. Observations showing that the product of cistron 13 is inactivated by trypsin and that it can be released from intact phage particles by osmotic shock followed by heat treatment suggest that this product is an integral protein constituent of the tail structure.
Extensive examination of several cistron 13 mutant lysates by electron microscopy indicated the presence of assembled tailless heads and the absence of any assembled free tails. This suggests that the cistron 13 product is necessary for assembly of tails from small subunits and is not merely involved in linking heads to preassembled tails.
The efficiency of the complementation reaction observed upon mixing appropriate lysates is relatively low. The number of active phage assembled is between 0.002 and 0.001 that found in nondefective lysates. This probably is inherent in the probability of effective collisions between the various interacting components. Earlier experiments on the kinetics of assembly of phage X from heads and tails showed that only about 1 in 100 of the collisions between the two particles is effective in assembly of an infective unit (14) . Since the 480 assembly reaction described above involves both tail assembly and subsequent joining of heads to tails, the probability of effective collisions would be expected to be much lower than one in a hundred, thus possibly explaining the low efficiency of assembly observed.
Several lysates of sus mutants of bacteriophage X (sus L, H, K, M, and G) were shown to contain a component that could replace the cistron 13 product in the in vitro complementation reaction. Bacteriophages X and 4)80 are related in several respects, and the above observation points to still another aspect of homology. Mutants in cistron I of X have thus far been shown to lack the ability to form the component corresponding to that of cistron 13 in 4)80, suggesting a correspondence between the two cistrons. More direct evidence for this is being sought by complementation studies among a large number of X sus mutants defective in tail formation.
